{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:10:15Z","timestamp":1793319015199,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ebiom.2021.103763","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T16:05:02Z","timestamp":1639757102000},"page":"103763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Reversible insulin resistance in muscle and fat unrelated to the metabolic syndrome in patients with acromegaly"],"prefix":"10.1016","volume":"75","author":[{"given":"Mai C.","family":"Arlien-S\u00f8borg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Dal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Alle","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Lyng","family":"H\u00f8gild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid Johannesson","family":"Hjelholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen B.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens O.L.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2021.103763_bib0001","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103763_bib0002","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"Moller","year":"2009","journal-title":"Endocr Rev"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103763_bib0003","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103763_bib0004","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/diabetes.50.10.2301","article-title":"Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure","volume":"50","author":"Nielsen","year":"2001","journal-title":"Diabetes"},{"issue":"7285","key":"10.1016\/j.ebiom.2021.103763_bib0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103763_bib0006","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/apha.12183","article-title":"Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity","volume":"210","author":"Nellemann","year":"2014","journal-title":"Acta Physiol (Oxf)"},{"issue":"5 Pt 1","key":"10.1016\/j.ebiom.2021.103763_bib0007","first-page":"E736","article-title":"Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans","volume":"260","author":"Bak","year":"1991","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0008","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/db06-0299","article-title":"Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance","volume":"56","author":"del Rincon","year":"2007","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103763_bib0009","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0010","first-page":"1012","article-title":"Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy","volume":"74","author":"Moller","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103763_bib0011","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/jc.2015-1917","article-title":"Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment","volume":"100","author":"Reyes-Vidal","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0012","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1210\/jc.2007-2780","article-title":"Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly","volume":"93","author":"Freda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0013","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/eje.1.02036","article-title":"Consensus statement: medical management of acromegaly","volume":"153","author":"Melmed","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0014","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/jc.2008-2332","article-title":"Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies","volume":"94","author":"Mazziotti","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7841","key":"10.1016\/j.ebiom.2021.103763_bib0015","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(73)92873-0","article-title":"Inhibition of insulin secretion by somatostatin","volume":"2","author":"Alberti","year":"1973","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103763_bib0016","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1210\/jc.2016-1806","article-title":"Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment","volume":"101","author":"Dal","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103763_bib0017","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1210\/jc.2011-0592","article-title":"Acute peripheral metabolic effects of intraarterial leg infusion of somatostatin in healthy young men","volume":"96","author":"Krusenstjerna-Hafstrom","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0018","first-page":"1789","article-title":"Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm","volume":"80","author":"Moller","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103763_bib0019","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1210\/jc.2014-2032","article-title":"Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly","volume":"99","author":"Neggers","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/er.2001-0022","article-title":"Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly","volume":"23","author":"Kopchick","year":"2002","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103763_bib0021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/endo.141.1.7263","article-title":"Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice","volume":"141","author":"Strowski","year":"2000","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0022","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0023","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103763_bib0024","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1210\/jc.2017-00047","article-title":"How to Measure Adipose Tissue Insulin Sensitivity","volume":"102","author":"Sondergaard","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103763_bib0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1113\/jphysiol.1955.sp005304","article-title":"The blood flow in skin and muscle of the human forearm","volume":"128","author":"Cooper","year":"1955","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103763_bib0026","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s003940170008","article-title":"Regional lean body mass and resting energy expenditure in non-obese adults","volume":"40","author":"Muller","year":"2001","journal-title":"Eur J Nutr"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103763_bib0027","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0026-0495(88)90110-2","article-title":"The theoretical bases of indirect calorimetry: a review","volume":"37","author":"Ferrannini","year":"1988","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103763_bib0028","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1152\/japplphysiol.00840.2014","article-title":"GAPDH and beta-actin protein decreases with aging, making Stain-Free technology a superior loading control in Western blotting of human skeletal muscle","volume":"118","author":"Vigelso","year":"2015","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103763_bib0029","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41387-018-0030-4","article-title":"Human adipose tissue protein analyses using capillary western blot technology","volume":"8","author":"Lu","year":"2018","journal-title":"Nutr Diabetes"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0030","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ijo.2010.5","article-title":"Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis","volume":"34","author":"Okorodudu","year":"2010","journal-title":"Int J Obes (Lond)"},{"issue":"28","key":"10.1016\/j.ebiom.2021.103763_bib0031","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","article-title":"JAK-STAT signaling: from interferons to cytokines","volume":"282","author":"Schindler","year":"2007","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103763_bib0032","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1210\/jc.2007-2414","article-title":"Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade","volume":"93","author":"Nielsen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0033","doi-asserted-by":"crossref","first-page":"E899","DOI":"10.1152\/ajpendo.00024.2006","article-title":"GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus","volume":"291","author":"Jorgensen","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103763_bib0034","doi-asserted-by":"crossref","first-page":"E333","DOI":"10.1152\/ajpendo.00431.2018","article-title":"Growth hormone signaling and action in obese versus lean human subjects","volume":"316","author":"Hogild","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103763_bib0035","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jc.2008-1385","article-title":"Impact of fasting on growth hormone signaling and action in muscle and fat","volume":"94","author":"Moller","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0036","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1210\/jc.2008-2624","article-title":"Free fatty acids inhibit growth hormone\/signal transducer and activator of transcription-5 signaling in human muscle: a potential feedback mechanism","volume":"94","author":"Moller","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"10.1016\/j.ebiom.2021.103763_bib0037","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000181579","article-title":"Growth hormone and body composition","volume":"33","author":"Bengtsson","year":"1990","journal-title":"Horm Res"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103763_bib0038","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11102-013-0471-7","article-title":"Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients","volume":"17","author":"Alexopoulou","year":"2014","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103763_bib0039","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0040","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1530\/EJE-10-1050","article-title":"Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry","volume":"164","author":"Fieffe","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103763_bib0041","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/EJE-10-1096","article-title":"Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved","volume":"164","author":"Kinoshita","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103763_bib0042","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12020-018-1745-7","article-title":"Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases","volume":"63","author":"He","year":"2019","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0043","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0035-1569277","article-title":"Evolution of Glucose Tolerance After Treatment of Acromegaly: A Study in 57 Patients","volume":"48","author":"Jonas","year":"2016","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0044","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/jcem-72-5-1048","article-title":"Peripheral glucose metabolism in acromegaly","volume":"72","author":"Foss","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103763_bib0045","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/BF00873216","article-title":"Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance","volume":"29","author":"Karlander","year":"1986","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103763_bib0046","first-page":"486","article-title":"Energy metabolism and substrate oxidation in acromegaly","volume":"80","author":"O'Sullivan","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0047","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.1994.tb01826.x","article-title":"Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults","volume":"41","author":"Jorgensen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ebiom.2021.103763_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154188","article-title":"Growth hormone upregulates ANGPTL4 mRNA and suppresses lipoprotein lipase via fatty acids: Randomized experiments in human individuals","volume":"105","author":"Hjelholt","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.ebiom.2021.103763_bib0049","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00005792-196311000-00002","article-title":"Roles of Insulin and Growth Hormone, Based on Studies of Forearm Metabolism in Man","volume":"42","author":"Zierler","year":"1963","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103763_bib0050","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118742","article-title":"Mechanism of free fatty acid-induced insulin resistance in humans","volume":"97","author":"Roden","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2021.103763_bib0051","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-020-05262-w","article-title":"Insulin resistance induced by growth hormone is linked to lipolysis and associated with suppressed pyruvate dehydrogenase activity in skeletal muscle: a 2 x 2 factorial, randomised, crossover study in human individuals","author":"Hjelholt","year":"2020","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103763_bib0052","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","article-title":"Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms","volume":"24","author":"Ueki","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103763_bib0053","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103763_bib0054","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ghir.2005.07.001","article-title":"Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity","volume":"15","author":"Dominici","year":"2005","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103763_bib0055","doi-asserted-by":"crossref","first-page":"E194","DOI":"10.1152\/ajpendo.00149.2004","article-title":"Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion","volume":"288","author":"Jessen","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"41","key":"10.1016\/j.ebiom.2021.103763_bib0056","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1038\/onc.2008.247","article-title":"The PTEN-PI3K pathway: of feedbacks and cross-talks","volume":"27","author":"Carracedo","year":"2008","journal-title":"Oncogene"},{"issue":"45","key":"10.1016\/j.ebiom.2021.103763_bib0057","doi-asserted-by":"crossref","first-page":"37489","DOI":"10.1074\/jbc.M506967200","article-title":"Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess","volume":"280","author":"Barbour","year":"2005","journal-title":"J Biol Chem"},{"issue":"32","key":"10.1016\/j.ebiom.2021.103763_bib0058","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1073\/pnas.0604628103","article-title":"Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN","volume":"103","author":"Taniguchi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"10.1016\/j.ebiom.2021.103763_bib0059","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J Biol Chem"},{"issue":"51","key":"10.1016\/j.ebiom.2021.103763_bib0060","doi-asserted-by":"crossref","first-page":"47944","DOI":"10.1074\/jbc.M104602200","article-title":"SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice","volume":"276","author":"Emanuelli","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0061","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103763_bib0062","doi-asserted-by":"crossref","first-page":"T69","DOI":"10.1530\/JME-17-0311","article-title":"IGF1 receptor signaling pathways","volume":"61","author":"Hakuno","year":"2018","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.ebiom.2021.103763_bib0063","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2017-02566","article-title":"Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies","author":"Cozzolino","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103763_bib0064","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2265.1992.tb01443.x","article-title":"Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly","volume":"36","author":"Ho","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103763_bib0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2265.2003.01876.x","article-title":"Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment","volume":"59","author":"Baldelli","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103763_bib0066","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/13543784.2014.942728","article-title":"Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors","volume":"23","author":"Giustina","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103763_bib0067","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/jc.2006-1578","article-title":"Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets","volume":"92","author":"Singh","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0068","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2265.1986.tb01663.x","article-title":"Effects of somatostatin analogue SMS 201-995 in normal man","volume":"24","author":"Davies","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103763_bib0069","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/jc.2008-1546","article-title":"Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study","volume":"94","author":"Colao","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103763_bib0070","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1074\/jbc.M610580200","article-title":"Analysis of lipolytic protein trafficking and interactions in adipocytes","volume":"282","author":"Granneman","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2021.103763_bib0071","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.molmet.2019.08.013","article-title":"Temporal patterns of lipolytic regulators in adipose tissue after acute growth hormone exposure in human subjects: A randomized controlled crossover trial","volume":"29","author":"Hjelholt","year":"2019","journal-title":"Mol Metab"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103763_bib0072","doi-asserted-by":"crossref","first-page":"e14373","DOI":"10.14814\/phy2.14373","article-title":"The acute effects of growth hormone in adipose tissue is associated with suppression of antilipolytic signals","volume":"8","author":"Hoyer","year":"2020","journal-title":"Physiol Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103763_bib0073","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1152\/ajpendo.00129.2018","article-title":"Growth hormone acts along the PPARgamma-FSP27 axis to stimulate lipolysis in human adipocytes","volume":"316","author":"Sharma","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 5","key":"10.1016\/j.ebiom.2021.103763_bib0074","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000191338","article-title":"Action of growth hormone in adipose tissue","volume":"48","author":"Richelsen","year":"1997","journal-title":"Horm Res"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103763_bib0075","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1530\/JME-13-0277","article-title":"Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease","volume":"52","author":"Nielsen","year":"2014","journal-title":"J Mol Endocrinol"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103763_bib0076","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1073\/pnas.0308617100","article-title":"Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]","volume":"101","author":"Stiles","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103763_bib0077","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/MCB.25.6.2498-2510.2005","article-title":"Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue","volume":"25","author":"Kurlawalla-Martinez","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103763_bib0078","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/MCB.25.3.1135-1145.2005","article-title":"Muscle-specific Pten deletion protects against insulin resistance and diabetes","volume":"25","author":"Wijesekara","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103763_bib0079","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1210\/jc.2016-3835","article-title":"Substrate Metabolism and Insulin Sensitivity During Fasting in Obese Human Subjects: Impact of GH Blockade","volume":"102","author":"Pedersen","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:12:40Z","timestamp":1762456360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421005570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":79,"alternative-id":["S2352396421005570"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103763","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversible insulin resistance in muscle and fat unrelated to the metabolic syndrome in patients with acromegaly","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103763"}}